ETAP-Lab associates with MIRCen to perform a MRI translationnal study in stroke
ETAP-Lab is pleased to announce a 12-month collaboration with the MIRCen imaging platform directed by Pr. Philippe Hantraye(French Atomic Energy Commission (CEA), Fontenay-aux-Roses, France). This collaboration is happening within the context of a specific project aimed at supporting the translation of an innovative drug for acute ischemic stroke from preclinic to clinic. ETAP-Lab is contributing its original thrombo-embolic stroke model in rats, while MIRCen brings its outstanding expertise in the field of MRI in rodents. Stroke is one of the most prevalent life-threatening conditions in